All hypertensive patients should keep their sugar lower than 90 mg%
New Delhi, July 08, 2016: "Hypertension is a risk factor for Type 2 diabetes. If not properly managed, it can lead to diabetes with subsequent high risk of kidney damage," said Padma Shri Awardee Dr KK Aggarwal – President Heart Care Foundation of India (HCFI) and Honorary Secretary General IMA.
Results of the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT–BPLA) study have shown that the major predictor of new-onset diabetes (NOD) in patients with hypertension is high baseline fasting plasma glucose levels of more than 90mg%. The risk increases by 5.8 times for each 18mg% rise above 90 mg%.
Other risk factors are higher weight, higher blood pressure, and higher triglyceride levels. High BP patients taking the drugs atenolol (beta blocker drug) regimen with or without a diuretic are also at risk. On the other hand, high BP patients on amlodipine (calcium blocker) ± perindopril (ACE inhibitor), with high good HDL cholesterol levels, moderate alcohol use, and age older than 55 years had protection from developing diabetes.
The clinical tip is to keep fasting sugar lower than the waist circumference.
Results of the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT–BPLA) study have shown that the major predictor of new-onset diabetes (NOD) in patients with hypertension is high baseline fasting plasma glucose levels of more than 90mg%. The risk increases by 5.8 times for each 18mg% rise above 90 mg%.
Other risk factors are higher weight, higher blood pressure, and higher triglyceride levels. High BP patients taking the drugs atenolol (beta blocker drug) regimen with or without a diuretic are also at risk. On the other hand, high BP patients on amlodipine (calcium blocker) ± perindopril (ACE inhibitor), with high good HDL cholesterol levels, moderate alcohol use, and age older than 55 years had protection from developing diabetes.
The clinical tip is to keep fasting sugar lower than the waist circumference.
No comments:
Post a Comment